News Careers Investors Home Open Search Business Overview Events Financials & Filings Fundamentals Stock Sustainability & Governance Resources Investors $9.9 BILLION FY 2020 SALES $0.96 ADJUSTED EPS1 IN 2020 $2.0 BILLION ADJUSTED FREE CASH FLOW1 IN 2020 Q3 2021 Recent Quarterly Results Q3 2021 Earnings Release and Financial Results Q3 2021 Financial and Operating Highlights Go to Q3 2021 EVENTS Boston Scientific at Evercore ISI 2021 HealthCONx Conference December 01, 2021 Webcast Go to Events REPORTS & FILINGS Annual Results and Proxy Statements 2020 Annual Report and Form 10-K 2020 Performance Report 2021 Proxy Statement Go to Reports & Filings BUSINESS OVERVIEW Presentations 2021 Investor Day 2021 Investor Day Replay 2021 J.P. Morgan Healthcare Conference GOVERNANCE INFORMATION Corporate Governance and Sustainability Governance Overview Board of Directors Corporate Citizenship An Open Letter from BSX Leadership on Standing Up to Intolerance & Racism Go to Governance Information Go to Stock Quote & Chart page 1 Non-GAAP measure; excludes certain GAAP items. For reconciliations of non-GAAP financial measures to the most directly comparable GAAP figures, please refer to our Financial Disclaimers and Non-GAAP Reconciliations. Safe Harbor for forward-looking statements This site contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like “anticipate,” “expect,” “project,” “believe,” “plan,” “estimate,” “intend” and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could differ materially from the expectations and projections expressed or implied by our forward looking statements. Factors that may cause such differences can be found in our most recent Form 10-K and Forms 10-Q filed or to be filed with the Securities and Exchange Commission under the headings “Risk Factors” and “Safe Harbor for Forward-Looking Statements.” Accordingly, you are cautioned not to place undue reliance on any of our forward-looking statements. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which they may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. Connect with Boston Scientific Investor Relations INVESTOR RELATIONS CONTACT 300 Boston Scientific Way Mailstop M405 Marlborough, MA 01752 BSXInvestorRelations@bsci.com QUICK LINKS Investor FAQs Contact Information Email Alerts Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Follow on Twitter Follow on Facebook Follow on LinkedIn Follow the rss feed ©2021 Boston Scientific Corporation or its affiliates. All rights reserved. Privacy Policy Terms of Use Copyright Notice Site Map